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Summary
Mitochondrial morphology within cells is controlled
by precisely regulated rates of fusion and fission [1–
4]. During programmed cell death (PCD), mitochondria
undergo extensive fragmentation [5–7] and ultimately
caspase-independent elimination through a process
known as mitoptosis [8]. Though this increased frag-
mentation is due to increased fission through the
recruitment of the dynamin-like GTPase Drp1 to mito-
chondria [9, 10], as well as to a block in mitochondrial
fusion [11, 12], cellular mechanisms underlying these
processes remain unclear. Here, we describe a mecha-
nism for the increased mitochondrial Drp1 levels
and subsequent stimulation of mitochondrial fission
seen during PCD. We observed Bax/Bak-mediated re-
lease of DDP/TIMM8a, a mitochondrial intermembrane
space (IMS) protein [13, 14], into the cytoplasm, where
it binds to and promotes the mitochondrial redistri-
bution of Drp1, a mediator of mitochondrial fission.
Using both loss- and gain-of-function assays, we
also demonstrate that the Drp1- and DDP/TIMM8a-
dependent mitochondrial fragmentation observed
during PCD is an important step in mitoptosis, which
*Correspondence: msheng@mit.edu (M.S.); blackstc@ninds.nih.
gov (C.B.)in turn is involved in caspase-independent cell death.
Thus, followingBax/Bak-mediated mitochondrial outer
membrane permeabilization (MOMP), IMS proteins re-
leased comprise not only apoptogenic factors such as
cytochrome c involved in caspase activation [15, 16]
but also DDP/TIMM8a, which activates Drp1-mediated
fission to promote mitochondrial fragmentation and
subsequently elimination during PCD.
Results and Discussion
Mitochondrial Fragmentation Is Involved
in Mitoptosis
Mitochondrial fragmentation occurs during PCD and
requires Drp1-mediated fission [10, 17] but not caspase
activation [18, 19], and we hypothesized that a specific
program of fragmentation-dependent mitochondrial elim-
ination may be activated during PCD. To test this, HeLa
cells were transiently cotransfected with expression vec-
tors for mito-YFP and either wild-type Drp1, dominant-
negative Drp1K38A, or vector alone. The next day, cell
death was initiated using staurosporine (STS) in the pres-
ence of the broad caspase inhibitor zVAD-fmk to prevent
apoptosis, and cells were observed for 9 hr (Figure 1A). In
control cells, mitochondria fragmented and subsequently
began to disappear. Interestingly, although in Drp1-
overexpressing cells mitochondrial fragmentation and
disappearance were accelerated, overexpression of
dominant-negative Drp1K38A resulted in a fused, intercon-
nected mitochondrial network [20], and mitochondria
were neither fragmented nor eliminated (Figure 1A). These
results suggest that Drp1-dependent mitochondrial fis-
sion is involved in the caspase-independent mitochon-
drial elimination dubbed mitoptosis [8, 18, 19].
To examine the effects of Drp1-mediated mitochon-
drial fission on mitoptosis further, we investigated
HeLa cells engineered so that expression of Drp1 or
Drp1K38A is induced by tetracycline [17]. Following in-
duction of Drp1 or Drp1K38A expression, these and con-
trol cells were left untreated or else treated for 9 hr with
STS or actinomycin D (ActD) in the presence of the
caspase inhibitor zVAD-fmk. Alternatively, cells were
treated with STS or ActD and zVAD-fmk as above,
washed, and returned for 3 days to medium containing
only thecaspase inhibitor. Mitochondrial content inwhole-
cell extracts was assessed by immunoblotting using
CoxIV, an inner mitochondrial membrane protein; actin
was used as a cytoskeletal marker (Figure 1B). Following
treatment with STS or ActD in the presence of zVAD-fmk
for 9 hr, mitochondrial disappearance was barely detect-
able. However, after these cells were returned to medium
containing only zVAD-fmk for 3 days, mitochondrial dis-
appearance as assessed using CoxIV levels was promi-
nent while actin levels were unaffected, in agreement
with previous reports [18, 19]. Mitochondrial elimination
was similarly observed when levels of other mitochon-
drial membrane proteins such as succinate-ubiquinol
oxidoreductase or NADH oxidoreductase were evalu-
ated (data not shown). Mitochondrial fragmentation
and ultimately elimination were confirmed by electron
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2113Figure 1. Mitochondrial Fragmentation Is Involved in Mitochondrial Elimination
(A) HeLa cells cotransfected with mito-YFP and either pcDNA3 (control), pcDNA3-Drp1K38A (Drp1K38A), or pcDNA3-Drp1 (Drp1) were treated with
1 mM STS in the presence of 100 mM zVAD-fmk, then images were acquired by confocal microscopy. Graphics show percent of total mito-YFP
fluorescence remaining at the indicated times as assessed using MetaMorph software. Data represent the means 6SD of 13 single-cell time-
lapse measurements per time point.
(B) T-Rex-V (control), T-Rex-Drp1 (Drp1), and T-Rex-Drp1K38A (K38A) HeLa cells [17] were pretreated with tetracycline to induce Drp1 and
Drp1K38A expression, then either left untreated or else treated for 9 hr with 1 mM STS or 10 mM ActD in the presence of zVAD-fmk (STS +
zVAD, ActD + zVAD). Alternatively, cells were treated with 1 mM STS or 10 mM ActD as well as zVAD-fmk for 9 hr, washed, and returned to medium
containing only zVAD-fmk (STS + zVAD > zVAD or ActD + zVAD > zVAD) for 3 days. Levels of mitochondrial and cytoskeletal markers in total cell
extracts were assessed by immunoblotting using anti-CoxIV and anti-actin antibodies, respectively (upper panel). Mitochondrial disappearance
after 3 days (STS + zVAD > zVAD) was investigated by transmission electron microscopy (lower panel). In control cells, arrows identify frag-
mented mitochondria within an autophagosome, and, in the Drp1K38A-expressing cells, arrows indicate mitochondria. In Drp1-overexpressing
cells, mitochondria are not seen, having undergone elimination.
(C) After tetracycline pretreatment, T-Rex-V (control), T-Rex-Drp1 (Drp1), and T-Rex-Drp1K38A (K38A) HeLa cells were treated for 9 hr with 1 mM
STS or 10 mM ActD in the presence of zVAD-fmk and then with new medium containing only zVAD-fmk, changed every 24 hr. Cell viability was
assessed by trypan blue exclusion at the indicated times. Data represent the means 6SD of four independent experiments, 300 cells per
condition.microscopy and, interestingly, fragmented mitochondria
were found within autophagosomes (Figure 1B). Impor-
tantly, mitochondrial disappearance was increased in
Drp1-expressing cells but inhibited in Drp1K38A-express-
ing cells (Figure 1B), further demonstrating that mito-
chondrial fragmentation depends on Drp1 and is in-
volved in caspase-independent mitoptosis.
Cell death can occur even in the absence of caspase
activation [21, 22], and we investigated whether mito-
ptosis might be involved in caspase-independent cell
death. Control or else Drp1- or Drp1K38A-expressing
cells were incubated for 9 hr with STS or ActD in the
presence of zVAD-fmk, then washed and returned to
media containing only zVAD-fmk. The percentage of liv-
ing cells was assessed periodically, and each day, cells
were incubated in fresh media containing zVAD-fmk. We
observed greater caspase-independent cell death in
Drp1-expressing cells than in controls, while Drp1K38A-expressing cells were more resistant (Figure 1C). In-
volvement of mitoptosis in caspase-independent cell
death was similarly demonstrated using cells in which
caspase-9 expression was suppressed using siRNA
(Figure S1). Thus, our results indicate that mitoptosis in-
volving Drp1-dependent mitochondrial fragmentation
participates in caspase-independent cell death.
Drp1 Binds DDP/TIMM8a, an IMS Protein Released
from Mitochondria during PCD
It is generally accepted that PCD occurs downstream of
Bax/Bak-mediated MOMP [15, 23], and we have ob-
served that Bcl-2 family members regulate mitochon-
drial fragmentation and subsequent mitoptosis during
PCD (Figure S2). Since Drp1-mediated fission is in-
volved in mitochondrial fragmentation during PCD [10]
and Bax overexpression increases mitochondrial frag-
mentation (Figure S2A), we considered the possibility
Current Biology
2114that Bax might also regulate Drp1 function. Since we and
others have observed that mitochondrial fragmentation
largely occurs downstream of Bax/Bak-mediated
MOMP [11, 24, 25], we hypothesized that Bax/Bak may
activate Drp1 indirectly via release of a mitochondrial
factor, reminiscent of the Bax/Bak-mediated trigger-
ing of caspase activation through the release of cyto-
chrome c [15].
Multiple yeast two-hybrid screens were performed
using Drp1 as well as several mitochondrial IMS proteins
as baits, searching for novel interactions. In a screen us-
ing the IMS protein DDP/TIMM8a as bait, an interaction
was found with a fragment of Drp1 (variant I) comprising
amino acid residues 294–736 (Figure 2A). All six strongly
positive clones corresponded to this fragment, and thus
DDP represented a compelling candidate for activation
and/or mitochondrial recruitment of Drp1. DDP is similar
in structure to several small yeast Tim and mammalian
TIMM proteins, all harboring a conserved ‘‘twin Cx3C’’
paired dicysteine motif, that are implicated in the
Figure 2. The Mitochondrial IMS Protein DDP/TIMM8a Interacts
with Drp1
(A) Yeast two-hybrid analyses of the DDP-Drp1 interaction. pBHA-
DDP/TIMM8a or the related baits TIMM8b or TIMM13b were tested
against the indicated pGAD10-Drp1 constructs. Drp1 domains are
indicated schematically: GTP, GTP binding domain; M, middle
domain; B, insert B; GED, a-helical GTPase effector domain.
Strength of interaction was assayed by b-gal and HIS3 induction
as described previously [33]. I, II, and III depict the known Drp1
splice variants, with deletions within the B insert of variants II and
III shown schematically.
(B) Extracts from COS-7 cells coexpressing Myc-Drp1(1–736)
and DDP were immunoprecipitated with anti-Drp1 antibodies and
immunoblotted for DDP. In control experiments, extracts from
DDP-transfected cells were mixed with extracts from Myc-Drp1-
transfected cells, then immunoprecipitated as above. ‘‘Input’’ repre-
sents 20% of the starting material, ‘‘flow thru’’ 20% of the superna-
tant from the anti-Drp1 immunoprecipitation, and ‘‘anti-Drp1’’ the
immunoprecipitate. ‘‘IgG’’ represents an immunoprecipitation
done with control nonimmune IgG.
(C) GST-DDP bound to glutathione beads was incubated in vitro
with extracts from cells overexpressing Myc-Drp1(1–736). Divalent
cations were added at 1 mM for Ca2+, Mg2+, Mn2+, and Ni2+ and
200 mM for Zn2+. Bound proteins were resolved by SDS-PAGE and
immunoblotted with anti-Myc antibodies. Multiple bands observed
for Drp1(1–736) likely reflect protein degradation, as these experi-
ments were conducted in the absence of metal chelators or protease
inhibitors.transport of transmembrane carrier proteins across the
aqueous IMS to the inner mitochondrial membrane [13,
14, 26]. However, yeast two-hybrid tests using human
TIMM proteins such as the DDP/TIMM8a paralog
TIMM8b (like DDP, orthologous to yeast Tim8) and
TIMM13b [13, 14] yielded no interactions with Drp1,
demonstrating the selectivity of the DDP-Drp1 interac-
tion. Drp1 exists in three known splice variants (I–III),
and all interact robustly with DDP (Figure 2A).
To confirm the DDP-Drp1 interaction in cells, we per-
formed coimmunoprecipitation studies. In cells overex-
pressing full-length Drp1(1–736) together with DDP,
anti-Drp1 antibodies coprecipitate a small fraction of
DDP (Figure 2B). In control experiments using postlysis
mixtures of detergent extracts from cells individually
expressing DDP or Drp1(1–736), no coimmunoprecip-
itation of DDP and Drp1 is observed, and immunopre-
cipitations using nonspecific IgG similarly revealed no
precipitation of DDP or Drp1 (Figure 2B; data not
shown). Normally, DDP is localized to the mitochondrial
IMS, while Drp1 is predominantly cytoplasmic. How-
ever, when overexpressed, a small portion of DDP is
cytoplasmic (data not shown; [27]), and thus the inter-
action with Drp1 may be occurring there. Lastly, many
known interactions of the small IMS Tim proteins are
stimulated by Zn2+ [28–33]. Using glutathione S-trans-
ferase (GST) ‘‘pull-down’’ experiments, we similarly
found that Drp1 binding to DDP in vitro was enhanced
markedly by the addition of Zn2+ or Mn2+ but not by
Ca2+ or Mg2+ (Figure 2C).
We narrowed down the interaction domains within
both Drp1 and DDP required for the DDP-Drp1 inter-
action. Deletion analyses of DDP revealed that the
N-terminal 17 and C-terminal 9 amino acids of DDP are
not required for strong interaction with Drp1. However,
a central region of DDP containing the conserved
‘‘twin Cx3C’’ motif (residues 35–74) bound very weakly
to Drp1 (Figure S3A). We generated a DDP-TIMM8b
chimera by replacing amino acid residues 59–97 of DDP
with the corresponding residues 52–83 of its shorter
paralog TIMM8b, retaining the conserved twin Cx3C
motif. The DDP-TIMM8b chimera did not interact
with Drp1(294–736), indicating that residues in the
C-terminal third of DDP are critical for the interaction
(Figure S3A).
We attempted to narrow down the interaction domain
within Drp1 required for DDP interaction using yeast
two-hybrid tests. A fragment comprising Drp1 residues
303–736 interacted robustly with DDP; however,
Drp1(316–736) exhibited a much weaker interaction,
and Drp1(1–489) did not interact at all (data not shown).
Thus, we pursued other techniques. Using a nuclear
redistribution assay [33], coimmunoprecipitation experi-
ments, and GST pull-downs, we found that Drp1(502–
736) was sufficient for strong interaction with DDP (Fig-
ures S3B–S3H). Thus, the interaction domain sufficient
for strong DDP binding was narrowed to residues 502–
736 of Drp1, which harbors the critical GTP-effector do-
main (GED) and B loop [34, 35] and is important for intra-
and intermolecular Drp1 interactions [35]. Interestingly,
it was recently reported that the GED domain of Drp1
alone targets specifically and exclusively to mitochon-
dria, supporting its involvement in localizing Drp1 to
mitochondria [36].
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(A) HeLa cells transfected with Myc-DDP were either left untreated or treated with 1 mM STS or 10 mM ActD for 8 hr, fixed, stained with anti-
cytochrome c (green) and anti-Myc (red) antibodies, and analyzed by confocal microscopy.
(B) HeLa cells or HeLa cells stably overexpressing Bcl-2 were treated for 7 and 9 hr with 1 mM STS or 10 mM ActD. Next, the cytosolic and heavy
membrane fractions were analyzed by immunoblotting for the presence of cytochrome c and DDP. As loading controls, actin was used for the
cytosolic fraction and CoxIV for the heavy membrane fraction.
(C) Mitochondria isolated from HeLa cells were incubated (20 min, 30ºC) with different concentrations (nM) of recombinant tBid. Mitochondrial
and supernatant fractions were resolved by SDS-PAGE and immunoblotted with antibodies against the indicated proteins. Mitochondria were
also incubated with (+) or without (2) 10 nM tBid at 30ºC, and the mitochondrial pellet and supernatant were analyzed at different time points.
Equal loading of the mitochondrial pellet lanes was monitored using anti-VDAC antibodies.
(D) Cytosolic fractions of untreated or else STS- (1 mM, 7 hr) or ActD- (10 mM, 7 hr) treated HeLa cells were immunoprecipitated using anti-Drp1
antibodies, and immunoblotted for DDP and Drp1. Immunoprecipitations using nonspecific IgG revealed no precipitation of DDP (data not
shown). ‘‘Input’’ represents 10% of the starting material. An asterisk identifies a probable DDP breakdown fragment.As mentioned previously, DDP is normally localized
within the mitochondrial IMS, separated from cytoplas-
mic Drp1 by the mitochondrial outer membrane. How-
ever, one scenario for a physiological interaction be-
tween Drp1 and DDP occurs during PCD, when some
IMS proteins are released into the cytoplasm after
MOMP [15, 16]. Indeed, immunocytochemical and cell
fractionation studies (Figures 3A–3B) confirm that DDP,
like cytochrome c, is released during PCD [37] as a con-
sequence of Bax/Bak-mediated MOMP, and its release
is prevented by the antiapoptotic protein Bcl-2 (Fig-
ure 3B).
Mitochondria isolated from HeLa cells were incubated
with recombinant tBid, a BH3-only member of the Bcl-2
family that requires either Bax or Bak to trigger MOMP
[23]. Both dose-escalation and kinetic studies in vitro
with tBid demonstrate that DDP and cytochrome c are
coreleased after MOMP (Figure 3C). Studies utilizingembryonic fibroblasts from knockout mice lacking
both Bax and Bak further confirmed that DDP requires
Bax and/or Bak to be coreleased with cytochrome c dur-
ing PCD (Figure S4). Since DDP was detected in the
cytosol of apoptotic cells (Figure 3B), we investigated
the interaction between DDP and Drp1 during PCD. By
coimmunoprecipitation, a robust interaction was de-
tected between DDP and Drp1 in the cytosol of apopto-
tic cells but not in nonapoptotic cells (Figure 3D). Thus,
an interaction between DDP and Drp1 occurs promi-
nently during PCD, prefiguring a role for released DDP
in the regulation of Drp1 function.
DDP Release Participates in Drp1 Mitochondrial
Recruitment/Retention and Subsequent Mitoptosis
Since Drp1 is recruited to and/or retained on mito-
chondria during PCD [9, 10] (Figure S2B), we studied
whether DDP binding might play a role. HeLa cells
Current Biology
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(A) HeLa cells transiently transfected with vector alone (Control), Myc-DDP (DDP), a Myc-DDP-TIMM8b chimera (Chimera), or Myc-TIMM13b
(TIMM13) were either left untreated or treated 9 hr with 1 mM STS or 10 mM ActD in the presence of 100 mM zVAD-fmk. Levels of Drp1 in the mi-
tochondrial fraction were assessed by immunoblotting, with CoxIV as a loading control. Expression of the Myc-tagged proteins was equal, as
determined by immunoblotting with anti-Myc antibodies (data not shown).
(B) In vitro-translated [35S]Drp1(294–736) was incubated with mitochondria isolated from either control or Bcl-2-overexpressing HeLa cells in the
presence or absence of in vitro-translated [35S]DDP. Levels of Drp1(294–736) were then evaluated in the supernatant (Sup) or mitochondrial pellet
after SDS-PAGE. VDAC was used as a loading control for the mitochondrial pellet.
(C) HeLa cells transiently transfected with vector alone (Control), Myc-DDP (DDP), or a DDP-TIMM8b chimera (Chimera) were either left untreated
or treated with 1 mM STS or 10 mM ActD with zVAD-fmk for 9 hr, washed, and returned for 3 days to medium containing only zVAD-fmk ([STS +
zVAD > zVAD] or [ActD + zVAD > zVAD]). Mitochondrial and actin levels were assessed as in Figure 1B.
(D) HeLa cells were transfected and treated as in (C), and cell viability was assessed at the indicated times using trypan blue exclusion. Data
represent means 6SD of three independent experiments, 300 cells per condition.
(E) HeLa cells were either left untransfected (none) or transfected with DDP siRNA 2 or control siRNA. Next, cells were either left untreated or
treated 9 hr with 1 mM STS or 10 mM ActD in the presence of zVAD-fmk. Levels of Drp1 in the mitochondrial fraction were then assessed by im-
munoblotting. CoxIV was used as a loading control.
(F) HeLa cells were either not transfected (none) or transfected with DDP siRNA 2 or control siRNA. Cells were then either left untreated or treated
with 1 mM STS or 10 mM ActD with zVAD-fmk for 9 hr, washed, and returned for 3 days to medium containing only zVAD-fmk [(STS + zVAD > zVAD)
or (ActD + zVAD > zVAD)]. Mitochondrial and cytoskeletal protein levels were assessed as in (C).
(G) HeLa cells were either not transfected (none) or transfected with DDP siRNA 2 or control siRNA as in (F) and then treated and analyzed for
viability using trypan blue exclusion. Data represent the mean 6SD of three independent experiments, 300 cells per condition.were transfected with either vector alone or a Myc-DDP
expression construct. As additional controls, we also
used constructs encoding a Myc-DDP-TIMM8b chimera
or Myc-TIMM13b, neither of which interacts with Drp1
(Figure 2A) but which, like Myc-DDP, localize to the
IMS (data not shown). Transfected cells were either left
untreated or else incubated with STS or ActD to induce
MOMP, then fractionated. Mitochondrial Drp1 levels
from Myc-DDP-overexpressing cells were increased af-
ter MOMP as compared to the levels in each of the differ-
ent controls (Figure 4A), suggesting that DDP binding to
Drp1 increases Drp1 recruitment to the mitochondria
and/or its retention there.
To determine whether binding to DDP is involved in
mitochondrial recruitment of Drp1, we employed an in
vitro system, using isolated mitochondria incubated
with in vitro-translated Drp1 and DDP. When full-length
Drp1 was incubated with mitochondria, its association
with mitochondria was barely detectable, even in the
presence of DDP (data not shown), suggesting thateither in vitro-translated full-length Drp1 was misfolded
or else that full-length Drp1 must undergo a confor-
mational change in vivo to facilitate its association with
mitochondria. However, a fragment of Drp1 lacking
most of the GTP binding domain but still capable of
binding DDP in yeast two-hybrid tests, Drp1(294–736)
(Figure 2A), associated spontaneously with mitochon-
dria in vitro (Figure 4B). Interestingly, in the presence
of DDP, the fraction of Drp1(294–736) in the mitochon-
drial pellet was increased (Figure 4B). In control experi-
ments, the addition of in vitro-translated TIMM13b,
which does not bind Drp1, had no effect on Drp1(294–
736) recruitment (data not shown). These data suggest
that Drp1(294–736) may mimic a Drp1 conformation
competent for mitochondrial association and that the
Drp1-DDP interaction may increase mitochondrial re-
cruitment of Drp1 during PCD, though it remains possi-
ble that it promotes retention as well. Overexpression
of Bcl-2 in cells prior to isolation of mitochondria had
no effect on the cell-free mitochondrial association of
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(Figure 4B).
Consistent with the observation that DDP-overex-
pressing cells have higher mitochondrial levels of Drp1
than control cells during PCD, upon treatment with ei-
ther STS or ActD we found that DDP-overexpressing
cells also showed an increase in mitoptosis in compari-
son to control and DDP-TIMM8b chimera- or TIMM13b-
transfected cells (Figure 4C; data not shown). In fact,
DDP-transfected cells not only showed an increase
in mitoptosis but were also more prone to caspase-
independent cell death (Figure 4D).
To investigate further the involvement of DDP in Drp1
mitochondrial recruitment/retention as well as mito-
chondrial fragmentation during PCD, DDP expression
was knocked down using siRNAs (Figure S5). Impor-
tantly, total cellular Drp1 levels were unchanged in
DDP siRNA-transfected cells, and DDP siRNA did not af-
fect apoptosis, mitochondrial morphology, or mitochon-
drial inner membrane cristae structure (Figure S5). Since
our earlier results suggested that DDP, once released
into the cytoplasm during PCD, binds to Drp1 and pro-
motes its mitochondrial localization (Figure 4A), we an-
ticipated that mitochondrial Drp1 levels would be de-
creased after cell death induction in cells lacking DDP,
as compared with control cells. This is indeed what we
observed (Figure 4E), confirming that DDP is a mediator
of Drp1 mitochondrial localization during PCD.
Given that the siRNA-mediated knockdown of DDP de-
creases mitochondrial levels of Drp1, we asked whether
knockdown of DDP also inhibits mitoptosis. Following
treatment with either STS or ActD, caspase-independent
mitoptosis occurs normally in untransfected or control
siRNA-transfected cells but is significantly prevented
in DDP siRNA-transfected cells (Figure 4F). Concordant
with this observation, DDP siRNA-transfected cells ap-
peared more resistant to caspase-independent cell death
in comparison to untransfected or control siRNA-trans-
fected cells (Figure 4G).
Conclusions
We report that increased mitochondrial fragmentation
during PCD occurs partly as a result of increased
Drp1-mediated mitochondrial fission through inter-
action of Drp1 with DDP/TIMM8a. We found that,
after Bax/Bak-mediated MOMP, DDP is released from
mitochondria into the cytoplasm, where it binds to the
C-terminal portion of Drp1. This interaction increases
Drp1 recruitment and/or retention to mitochondria,
where Drp1 promotes mitochondrial fission and, subse-
quently, mitoptosis. Though the molecular mechanisms
whereby DDP increases Drp1 mitochondrial levels dur-
ing PCD remain unclear, DDP binding to Drp1 may cause
changes in Drp1 oligomerization or increased affinity of
Drp1 for another protein that mediates its mitochondrial
localization. Alternatively, DDP may ‘‘chaperone’’ Drp1
directly to the mitochondrial surface.
Though our results regarding the timing of release of
DDP and cytochrome c relative to mitochondrial frag-
mentation during PCD are consistent with a number of
previous studies [11, 24, 25, 38], they appear at odds
with some models of mitochondrial fragmentation dur-
ing PCD [38]. Some investigators have suggested that
fragmentation is required for release of apoptogenicfactors from the IMS, since overexpression of dominant-
negative Drp1K38A results in long, fused mitochondria by
inhibiting mitochondrial fission [10], and cytochrome c is
not released during apoptosis [38]. However, we have
found that DDP and other apoptogenic IMS proteins
such as Smac/DIABLO and Omi/HtrA2 are released in
the Drp1K38A-expressing cells, indicating that MOMP
has occurred (Figure S6; data not shown), while cyto-
chrome c is still retained. Thus, the retention of cyto-
chrome c under these conditions is likely due to mecha-
nisms other than a general block of MOMP and does not
necessarily reflect the behavior of other IMS proteins.
Lastly, many reports have described autophagic cell
death as an alternative form of PCD [39, 40]. Interest-
ingly, during autophagic cell death, fragmented mito-
chondria are found within autophagosomes (Figure 1B;
[41, 42]). Since we report here that mitoptosis is initiated
after Bax/Bak-mediated MOMP, autophagic cell death
could also be a consequence of MOMP [41, 42], and
DDP may play a role. Further studies of the regulation
of Drp1 function during PCD will be important to clarify
the physiological role of the DDP interaction in these
processes.
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